NGM Biopharmaceuticals Obtains $51,000,000 Series B Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ed7bae3b-3c45-4427-bad6-d9b8b1b7c06f&Preview=1
-
Date
3/15/2010
-
Company Name
NGM Biopharmaceuticals
-
Mailing Address
630 Gateway Blvd South San Francisco, CA 94080-7014
-
Company Description
The company is focused on developing treatments for metabolic diseases.
-
Website
http://www.ngmbio.com
-
Transaction Type
Venture Equity
-
Transaction Amount
$51,000,000
-
Transaction Round
Series B
-
Proceeds Purposes
Proceeds purposes were not disclosed.
-
M&A Terms
-
Venture Investor
The Column Group
-
Venture Investor
Tichenor Ventures
-
Venture Investor
Prospect Venture Partners
-
Venture Investor
Rho Ventures
Add Your Thoughts
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.
